We at R.T. Mat. are convinced that Bioplant^® HTR^® Bone Regenerating Material has superior qualities. And this we don' t say for granted.
An impressive list of more than 270 scientific publications, whereof the unmatched succes of Bioplant^® HTR^® bot-regeneration material seems, is available on simple request (see below).
Clinical studies on Bioplant^® HTR^®, on both human and animal tissues are available. In every clinical test, there have been no adverse effects or rejection of the material. Until now not one complaint has been received about undesired consequences of the Bioplant^® HTR^® material.
Hard Tissue Replacement has been approved by the American Food and Drug administration (FDA) 510 K for :

• All dental appliencies, included ridge preservation
• implant dentistery
• ridge augmentation
• the treatment of periodontal defects.

Hard Tissue Replacement also has the CE notification and the ISO 9002 certificat for marketing and sales on the European market.

Below you can find the till today published scientific studies about the qualities and appliencies of Bioplant® HTR®. When you are interested in one or more of these publications, push on:

and send us a mail, together with the number(s) of the studie(s) you want to receive. Most of these studies can be supplied out of our own bibliographie at our headquarters in Mechelen. They can be received within a few days by regular post. Only a few have to be ordered at Bioplant Inc. USA. We will give notice of the temporary delay. Publications are organized in defind groups.
Push on the button to select the subject of your choice.